Friday 6 November 2026
Export HNGE’s income statement to Excel — free account
Hinge Health Inc.
HNGE Healthcare Health Information Services
Hinge Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $587.9 million, up 50.6% from fiscal 2024.
- Revenue
- +53.0%
- EPS
- +104.2%
- Free cash flow
- +441.1%
Quarter to June 2026, against a year earlier
115.84
0.14
−0.12%
Follow HNGE
Alert me
Hinge Health Inc. (HNGE) Revenue
Hinge Health Inc.'s revenue for fiscal 2025 was $587.9M, up 50.6% from $390.4M in fiscal 2024. Over the twelve months to 30 June 2026 it was $720.1M. Hinge Health Inc. ranks 12th of 42 Health Information Services companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $587.9M | 50.58% |
| FY2024 | $390.4M | 33.37% |
| FY2023 | $292.7M | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $212.8M | 16.74% |
| Mar 2026 | $182.3M | 6.78% |
| Dec 2025 | $170.7M | 10.71% |
| Sep 2025 | $154.2M | 10.87% |
| 4 more quarters | Free account |
Revenue against peers
| Company | Revenue |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | $15.3B |
| PRVA Privia Health Group, Inc. compare | $2.4B |
| TEM Tempus AI, Inc. compare | $1.5B |
| HQY HealthEquity, Inc. compare | $1.4B |
| WAY Waystar Holding Corp. compare | $1.3B |
| HNGE Hinge Health Inc. | $720.1M |
| DOCS Doximity, Inc. compare | $661.6M |
| SDGR Schrodinger, Inc. compare | $269.2M |
| HTFL Heartflow, Inc. compare | $212.1M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on HNGE
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement